Decreasing fibrogenesis: An immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B

Young Oh Kweon, Zachary D. Goodman, Jules L. Dienstag, Eugene R. Schiff, Nathaniel A. Brown, Elmar Burkhardt, Robert Schoonhoven, David A. Brenner, Michael W. Fried

Research output: Contribution to journalArticle

153 Scopus citations

Abstract

Background: Activation of hepatic stellate cells is the earliest step in fibrogenesis. Alpha-smooth muscle actin (α-SMA), expressed by activated hepatic stellate cells, and C-terminal procollagen α1(III) propeptide (PIIICP) are early markers of fibrogenesis and should precede fibrosis. Aim: Determine if suppression of hepatitis B virus replication with lamivudine would decrease fibrogenesis as measured by immunohistochemical markers. Methods: Paired liver biopsies from patients with hepatitis B before and after therapy with lamivudine (n = 47) or placebo (n = 33) were studied, α-SMA and PIIICP were detected in paraffin-embedded tissue by immunohistochemistry and quantified in a blinded manner by video imaging analysis. Results: Liver biopsies from patients treated with lamivudine showed a significant decrease in α-SMA expression (1.06 ± 0.23 vs. 0.58 ± 0.11, pre vs. post, P < 0.05). Placebo recipients had increased levels of α-SMA (0.82 ± 0.14 vs. 1.32 ± 0.21, P < 0.05). PIIICP was similarly decreased after lamivudine. Among subjects whose Histologic Activity Index fibrosis score was unchanged or worsened, the mean change in α-SMA expression was significantly decreased in the lamivudine group compared with placebo. Conclusions: Lamivudine decreased markers of hepatic stellate cell activation and collagen synthesis. Immunohistochemical techniques are sensitive for assessing fibrogenesis and will be useful in trials of antiviral and antifibrotic agents.

Original languageEnglish (US)
Pages (from-to)749-755
Number of pages7
JournalJournal of Hepatology
Volume35
Issue number6
DOIs
StatePublished - Dec 1 2001

    Fingerprint

Keywords

  • α-Smooth muscle actin
  • C-terminal procollagen α1(III) propeptide
  • Fibrosis
  • Hepatic stellate cell
  • Hepatitis B
  • Immunohistochemistry
  • Lamivudine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Kweon, Y. O., Goodman, Z. D., Dienstag, J. L., Schiff, E. R., Brown, N. A., Burkhardt, E., Schoonhoven, R., Brenner, D. A., & Fried, M. W. (2001). Decreasing fibrogenesis: An immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. Journal of Hepatology, 35(6), 749-755. https://doi.org/10.1016/S0168-8278(01)00218-5